28 results
8-K
EX-10.1
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access
8-K
EX-10.1
16gvkrkds86qd c1
1 Feb 24
Entry into a Material Definitive Agreement
4:09pm
424B3
ajngjp
4 Apr 23
Prospectus supplement
4:57pm
POS AM
h471m7ebt4grtz
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm
8-K
EX-10.1
txazz4 lm2i8fk7r
16 May 22
Entry into a Material Definitive Agreement
9:49pm
424B4
dis 1maqu9twq
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
EX-1.1
qnpnxsyjec
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
DRS
EX-1.1
agzvqgdx2
2 Jun 21
Draft registration statement
12:00am
DRS
zumdawgiuk w4
2 Jun 21
Draft registration statement
12:00am
10-K
vizlgz
31 Mar 21
Annual report
2:14pm
424B4
amatp axq2
28 Dec 20
Prospectus supplement with pricing info
6:04am